Pfizer postpones FDA application on COVID shot for kids under 5

As of Feb. 11, Pfizer-BioNTech has postponed its application to the Food and Drug Administration to expand the use of its COVID-19 vaccine for children in the age range of 6 months to 4 years. File footage shows a Pfizer-BioNTech facility in Belgium.